SHANGHAI KECHOW PHARMA INC has a total of 11 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2012. It filed its patents most often in Australia, China and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are SMITHKLINE BEECHAM CORP, LABORATORIOS ALMIRALL S A and SERVIER LAB.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | China | 2 | |
#3 | United States | 2 | |
#4 | Canada | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Hong Kong | 1 | |
#7 | New Zealand | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds | |
#5 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Tian Hongqi | 11 |
#2 | Huang Gongchao | 9 |
#3 | Cheng Ying | 9 |
#4 | Kong Li | 8 |
#5 | Ji Conghui | 8 |
#6 | Liu Chunlei | 7 |
#7 | Wang Yueying | 1 |
#8 | Zhang Qianru | 1 |
#9 | Liu Yahong | 1 |
#10 | Zhu Zhimei | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020249120A1 | Use of aminothiol compounds as cerebral nerve or heart protective agent | |
CN105712992A | Compound serving as cMet inhibitor and preparation method and application of compound | |
CN103204825A | Benzothiazole compounds as protein kinase inhibitors, and preparation method and application thereof |